Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascletis, Blue Earth, Bone Therapeutics, Caladrius, Cellectar, Clearside, Clovis, Gannex, GSK, GT, Helsinn, Lipocine, Merus, Mesoblast, Ox2, Resverlogix, Rezolute, Roche, Taiho, Terns, Vir, Vitalis.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Aptevo, Aslan, Biomarin, Can-Fite, Cara, Celon, Codagenix, Dalcor, Dr. Reddy's, Edesa, Inflarx, Jupiter Orphan, Kintor, Lilly, Mediwound, Mesoblast, Neurorx, Oric, Redhill, Relief, Ultimovacs.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biogen, Can-Fite, Denovo, Dynavax, Dermbiont, Felix, Gradalis, Graybug, Inmed, Immutep, Leading Bio, Northsea, Oncosec, Prilenia, Proqr, Remd, Rhovac, Sarepta, Translate Bio, Ultragenyx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Immunovia.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Aldeyra, Alnylam, AM-Pharma, Basilea, Pfizer, Pharmaessentia.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Mitre Medical, Neurolief, Sensory Cloud.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Creative Medical, Erasca, Imara, Infinity, Inovio, Millendo, Mycovia, Ocuphire, Regenxbio, Seres, Vir, Windtree, Zentalis.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Arcturus, Direct Biologics, Emergent Biosolutions, Kaleido, Neurorx, Nicox, Ocumension, Redhill, Regeneron, Relief, Sinopharm, Tiziana Life Sciences.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Aeglea, Arch, Asclepix, Atyr, Bioxcel, Cerecor, Chemomab, Cyclo, Destiny, Genmab, Ideaya, Inflarx, Inhibrx, Metacrine, Ocuphire, Replimune, Sanbio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aptinyx, Biohaven, Calithera, Dicerna, F-star, Harpoon, Insmed, Kaleido, Kendrion, Landos, Mei, Pandion, Wu, Tiziana.